Primrose Therapeutics

Healthcare 📍 New York, United States 👥 1-10 employees 💰 $753K raised 📅 Founded 2010

Primrose Therapeutics, Inc. is a biotechnology company focused on the development of treatments for Polycystic Kidney Disease (PKD). PKD is one of the most common life-threatening genetic disorders, affecting 600,000 Americans and 12.5 million people worldwide -- more than cystic fibrosis, muscular dystrophy, hemophili

🌐 Website ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

1-10

Total Raised · Venture

$753K

Founded

2010

Cloud

Unknown

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	🔒 Subscribers only
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$18K – $45K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from Primrose Therapeutics's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction